iShares US Pharmaceuticals ETF
Health/Biotechnology
IHE
400 Howard Street,
San Francisco , CA, 94105
San Francisco , CA, 94105
Price
-
$ 68.49
0 %
-0.47
Dec 9, 2024
- Last Close
- Net Assets
-
$630M
Feb 23, 2024
- 52-Week High/Low
- $185.76 - $62.59
- Expense Ratio
- -
Link
Directors
Jun 14, 2023- John E. Kerrigan
- Richard L. Fagnani
- Robert S. Kapito
- Drew E. Lawton
- John E. Martinez
- Salim Ramji
- Madhav V. Rajan
- Jane D. Carlin
- Cecilia H. Herbert
Chief Compliance Officer
- Charles Park
Company Name |
Holding |
| More | 4.51 % |
Documents
Returns +
Q
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Q1 | -63.4% | -5.8% | -1.9% | -1% | -15.8% | 9.8% |
| Q2 | -1.7% | 2.2% | -1.3% | 6.3% | 14.3% | -2.5% |
| Q3 | - | -1.2% | -11.5% | -1.4% | 5.2% | -7.5% |
| Q4 | - | 5.4% | 9.8% | 9% | 9.1% | 13.7% |
Returns +
M
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -65.7% | 6.7% | 0% | -5.7% | 1.3% | - | - | - | - | - | - | - |
| 2023 | -0.3% | -5.1% | -0.5% | 3.4% | -5.2% | 4.3% | 1.8% | 4.1% | -6.7% | -5.4% | 4.8% | 5.7% |
Returns +
A
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -65% | -0.4% | -6% | 12.2% | 10.4% | 14% | -7.8% | 10.6% | -11.7% | 8.5% | 29.9% |